Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential

Psychopharmacology

Volumn 169, Issue 2, 2003, Pages 150-160

  Bain, John N ^a   Prendergast, Mark A ^c   Terry, Alvin V ^a,b   Arneric, Stephen P ^d,e   Smith, Mark A ^d,f   Buccafusco, Jerry J ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d DUPONT COMPANY   (United States)

^e PFIZER INC   (United States)

^f ASTRAZENECA   (United Kingdom)

Author keywords

Attention; Delayed matching; Dopamine agonist; Drug abuse; Monkey; Operant task

Indexed keywords

AMPHETAMINE DERIVATIVE; ATOMOXETINE; CAFFEINE; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; METHYLPHENIDATE; MORPHINE; NICOTINE; NOMIFENSINE; NORADRENALIN UPTAKE INHIBITOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ATTENTION; COGNITION; CONTROLLED STUDY; DRUG ABUSE; DRUG EFFECT; FEMALE; INSTRUMENTAL CONDITIONING; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SPECIES DIFFERENCE; TASK PERFORMANCE;

ANIMALS; ATTENTION; CAFFEINE; COGNITION; COGNITION DISORDERS; COLOR PERCEPTION; FEMALE; MACACA MULATTA; MACACA NEMESTRINA; MALE; METHYLPHENIDATE; MORPHINE; NEUROPSYCHOLOGICAL TESTS; NICOTINE; NOMIFENSINE; PHOTIC STIMULATION; PROPYLAMINES; SUBSTANCE-RELATED DISORDERS; TASK PERFORMANCE AND ANALYSIS;

EID: 0141742528     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1483-1     Document Type: Article

References (41)

1. Bardo MT (1998) Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit Rev Neurobiol 12:37-67
2. Bartus RT (2000) On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 163:495-529
3. Biederman J, Spencer T (1999) Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 46:1234-1242
4. Buccafusco JJ, Terry AV Jr (2000) Multiple CNS targets for eliciting beneficial effects on memory and cognition. J Pharmacol Exp Ther 295:438-446
5. Bushnell PJ (2001) Assessing attention in rats. In: Buccafusco JJ (ed) Methods of behavior analysis in neuroscience. CRC Press, New York, pp 111-121
6. Bushnell PJ, Levin ED, Marrocco RT, Sarter MF, Strupp BJ, Warburton DM (2000) Attention as a target of intoxication: insights and methods from studies of drug abuse. Neurotoxicol Teratol 22:487-502
7. Carelli RM, Deadwyler SA (1997) Cellular mechanisms underlying reinforcement-related processing in the nucleus accumbens: electrophysiological studies in behaving animals. Pharmacol Biochem Behav 57:495-504
8. Carlezon WA Jr, Devine DP, Wise RA (1995) Habit-forming actions of nomifensine in nucleus accumbens. Psychopharmacology 122:194-197
9. Challman TD, Lipsky JJ (2000) Methylphenidate: its pharmacology and uses. Mayo Clinic Proc 75:711-721
10. Chiueh CC, Moore KE (1975) Blockade by reserpine of methyl-phenidate-induced release of brain dopamine. J Pharmacol Exp Ther 193:559-563
11. Day JC, Fibiger HC (1992) Dopaminergic regulation of cortical acetylcholine release. Synapse 12:281-286
12. Day JC, Tham CS, Fibiger HC (1994) Dopamine depletion attenuates amphetamine-induced increases of cortical acetylcholine release. Eur J Pharmacol 263:285-292
13. Di Chiara G, Tanda G, Bassareo V, Pontieri R, Acquas E, Fenu S, Cadoni C, Carboni E (1999) Drug addiction as a disorder of associative learning: role of the nucleus accumbens shell/extended amygdala dopamine. Ann NY Acad Sci 877:461-485
14. Ehsanullah RS, Turner P (1977) Effects of nomifensine in vitro on uptake of 5-hydroxytryptamine and dopamine into human platelets. Br J Clin Pharmacol 4:159S-163S
15. Govoni S, Petkov VV, Montefusco O, Missale C, Battaini F, Spano PF, Trabucchi M (1984) Differential effects of caffeine on dihydroxyphenylacetic acid concentrations in various rat brain dopaminergic structures. J Pharm Pharmacol 36:458-460
16. Hudzik TJ, Wenger GR (1993) Effects of drugs of abuse and cholinergic agents on delayed matching-to-sample responding in the squirrel monkey. J Pharmacol Exp Ther 265:120-127
17. Imperato A, Mulas A, DiChiara G (1986) Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 132:337-338
18. Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97-129
19. 192IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AchE-positive fiber density. Behav Neurosci 110:247-265
20. McGinty JF (1999) Advancing from the ventral striatum to the extended amygdala: implications for neuropsychiatry and drug abuse. Ann NY Acad Sci 877:835
21. Mesulam MM (1990) Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol 28:597-613
22. Missale C, Castelletti L, Govoni S, Spano PF, Trabucchi M, Hanbauer I (1985) Dopamine uptake is differentially regulated in rat striatum and nucleus accumbens. J Neurochem 45:51-56
23. Mumford GK, Holtzman SG (1991) Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat. J Pharmacol Exp Ther 258:857-865
24. O'Neill WM, Hanks GW, Simpson P, Fallon MT, Jenkins E, Wesnes K (2000) The cognitive and psychomotor effects of morphine in healthy subjects: a randomized and controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo. Pain 85:209-215
25. Paule MG, Bushnell PJ, Maurissen JPJ, Wenger GR, Buccafusco JJ, Chelonis JJ, Elliott R (1998) Symposium overview: the use of delayed matching-to-sample procedures in studies of short-term memory in animals and humans. Neurotoxicol Teratol 20:493-502
26. Powell KR, Koppelman LF, Holtzman SG (1999) Differential involvement of dopamine in mediating the discriminative stimulu effects of low and high doses of caffeine in rats. Behav Pharmacol 10:707-716
27. Prendergast MA (2000) Assessment of distractibility in non-human primates performing a delayed matching-to-sample task. In: Buccafusco JJ (ed) Methods of behavior analysis in neuroscience. CRC Press, New York, pp 123-140
28. Prendergast MA, Jackson WJ, Terry AV Jr, Kille NJ, Arneric SP, Decker MW, Buccafusco JJ (1998a) Age-related differences in distractibility and response to methylphenidate in monkeys. Cereb Cortex 8:164-172
29. Prendergast MA, Jackson WJ, Terry AV Jr, Decker MW, Arneric SP, Buccafusco JJ (1998b) Central nicotinic receptor agonists ABT-418, ABT-089 and (-)-nicotine reduce distractibility in adult monkeys. Psychopharmacology 136:50-58
30. Rezvani AH, Levin ED (2001) Cognitive effects of nicotine. Biol Psychiatry 49:258-267
31. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291
32. Sarter M, Bruno JP (1999) Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders. Trends Neurosci 22:67-74
33. Sarter M, Bruno JP, Turchi J (1999) Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders. Ann NY Acad Sci 877:368-382
34. Schulze GE, Paule MG (1991) Effects of morphine sulfate on operant behavior in rhesus monkeys. Pharmacol Biochem Behav 38:77-83
35. Setlow B (1997) The nucleus accumbens and learning and memory. J Neurosci Res 49:515-521
36. Siegfried K, Taeuber K (1984) Pharmacodynamics of nomifensine: a review of studies in healthy subjects. J Clin Psychiatry 45:33-38
37. Spencer T, Biederman J, Wilens T, Prince J, Hatch M, Jones J, Harding M, Faraone SV, Seidman L (1998) Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry 155:693-695
38. Tidey JW, Bergman J (1998) Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. J Pharmacol Exp Ther 285:1163-1174
39. Warburton DM (1995) Effects of caffeine on cognition and mood without caffeine abstinence. Psychopharmacology 119:66-70
40. Westerink BHC, Kork J (1976) Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs. Eur J Pharmacol 38:281-291
41. Zerbe RL, Rowe H, Enas GG, Wong D, Farid N, Lemberger L (1985) Clinical pharmacology of tomoxetine, a potential antidepressant. J Pharmacol Exp Ther 232:139-143